The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is accepting letters of intent now through Monday, November 3, 2025, for its third round of funding. Funded projects will be eligible for up to $500,000 over two years, inclusive of indirect costs.
The program supports two-year research projects at the basic or early-stage translational stages that are designed to elucidate the fundamental biology of why and how sporadic forms of FTD develop.
An informal informational webinar for interested applicants will be held on Tuesday, October 14, 2025, at 11 a.m. US Eastern Time (8 a.m. Pacific Time, 5 p.m. Central European Time). Attendees must register using this Zoom registration link.
A recording of the webinar will be posted to this page following the session.
Interested applicants must submit a letter of intent by November 3, 2025, to be considered for the program’s third round of funding. Please see the full Request for Proposals for additional information.
Related Content
-
Kissick Family Foundation FTD Grant Program: 2025 Awardees and Projects
In September 2025, the Kissick Family Foundation, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), awarded four two-year grants to basic and early-stage translational research...Read Article -
A Global Imperative to Improve Brain Health
Age-related neurological and psychiatric diseases—including dementia, stroke, and late-life depression (LLD)—remain a major and growing public health challenge, as the global population over age 60 is expected to double by 2050.Read ReportSP TP
Agnes Stephens, Ishita Das, PhD, Katherine Eyring, PhD, Sylvie Raver, PhD, Samantha Kost, PhD, and Tanisha London, PhD -
Kissick Family Foundation, Milken Institute Announce $2 Million in Funding for Frontotemporal Dementia Research and New Call for Proposals
September 15, 2025 (Washington, DC)—The Kissick Family Foundation, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), today announced that the Kissick Family Foundation...Read ArticleImageSam Roth
Associate Director, Media RelationsSam Roth is the associate director of media relations for the Milken Institute. Based out of the Washington, DC, office, she oversees media coverage for the Health and Strategic Philanthropy pillars. -
Uterine Leiomyosarcoma: A Giving Smarter Guide
This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...Read Report -
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that has challenged patients, their families, and the medical community for generations. Although ALS is considered rare, its impact on...Read ReportMH
-
Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program (2025-2026)
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund a third cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop. In partnership with the Milken...Read Article -
A Call to Action for Science Funding Solutions at Global Conference 2025
At the Milken Institute’s Global Conference, we saw robust debate about the future of science in the United States. Members of the current administration focused outlined their goals to advance science which included “to achieve and...Read ArticleImageCara Altimus, PhD
Managing Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic PhilanthropyCara Altimus, PhD is a managing director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy, leading the science and health innovation portfolio. A PhD neuroscientist, Altimus advises individual philanthropists and foundations on the state of research for various areas including neurodegenerative disease and mental health, identifying opportunities where their capital can make the biggest impact. -
Tambourine Philanthropies Commits Over $5 Million in New Funding for Research into ALS, in Partnership with the Milken Institute
WASHINGTON, DC (April 30, 2024) — Tambourine Philanthropies (Tambourine), in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is pleased to announce the recipients of its ALS...Read Article -
Frontotemporal Dementia Giving Smarter Guide
Frontotemporal dementia (FTD) refers to a family of neurodegenerative conditions that cause changes in behavior, mood, executive function, language, memory, and motor function. FTD is widely believed to be underdiagnosed and undercounted...Read ReportMM